Myeloma news from the 2014 annual meeting of the American Society of Clinical Oncology has included updates on proteasome inhibitors, overcoming drug resistance, monoclonal antibodies and more. In this brief video, Dr. James Berenson, a leading myeloma researcher and physician, gives an overview with a focus on what’s important for patients today.
JAK inhibitors Transcript
So, we've been working on this class of drugs [JAK inhibitors] now for about 5 or 6 years, both in our research...